Managing pulmonary nontuberculous mycobacterial infection. time for a patient-centered approach.

  title={Managing pulmonary nontuberculous mycobacterial infection. time for a patient-centered approach.},
  author={Giovanni Satta and Timothy D McHugh and James Mountford and Ibrahim Abubakar and Marc Lipman},
  journal={Annals of the American Thoracic Society},
  volume={11 1},
The incidence of nontuberculous mycobacteria is increasing worldwide. However, the evidence base for clinical management comprises mostly expert opinion, case series, and few randomized clinical trials. Most currently recommended treatment regimens entail prolonged use of multiple antimicrobial agents associated with multiple self-limited and persistent potential adverse effects, including irreversible impairments of hearing, vision, and kidney function. Yet, little is known about how treatment… CONTINUE READING

From This Paper

Figures, tables, and topics from this paper.


Publications citing this paper.
Showing 1-10 of 15 extracted citations

Pneumothorax associated with nontuberculous mycobacteria

Medicine • 2016
View 6 Excerpts
Highly Influenced

The devil we know: is the use of injectable agents for the treatment of MDR-TB justified?

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease • 2017


Publications referenced by this paper.
Showing 1-10 of 39 references

Clinical and microbiologic outcomes in patients receiving treatment for Mycobacterium abscessus pulmonary disease.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America • 2011

out]. Kekkaku 2011;86:113–125

SW Ryoo, S Shin, +4 authors YK Park

Similar Papers

Loading similar papers…